Getting pharmaceutical R&D back on target

Nature Chemical Biology

Volumn 7, Issue 6, 2011, Pages 335-339

  Bunnage, Mark E ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN;

COST UTILITY ANALYSIS; DRUG APPROVAL; DRUG DESIGN; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG RESEARCH; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; FUNCTIONAL PROTEOMICS; GOOD MANUFACTURING PRACTICE; NOTE; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; QUALITY CONTROL;

EID: 79956140184     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio.581     Document Type: Note

References (26)

1. Bernstein Research Pipeline Report, February 2011 (Bernstein, 2011).
2. Adams, C.P. & Brantner, V.V. Health Econ. 19, 130-141 (2010).
3. Hopkins, A.L & Groom, C.R. Nat. Rev. Drug Discov. 1, 727-730 (2002).
4. Edwards, A.M. et al. Nature 470, 163-165 (2011).
5. Bedford, L. et al. Nat. Rev. Drug Discov. 10, 29-46 (2011).
6. Cohen, P. & Tcherpakov, M. Cell 143, 686-693 (2010).
7. Buchwald, P. IUBMB Life 62, 724-731 (2010).
8. Wells, J.A. & McClendon, C.L. Nature 450, 1001-1009 (2007).
9. Filippakopoulos, P. et al. Nature 468, 1067-1073 (2010).
10. Nicodeme, E. et al. Nature 468, 1119-1123 (2010).
11. De Luca, L. Bioorg. Med. Chem. 18, 7515-7521 (2010).
12. Kritzer, J.A. Nat. Chem. Biol. 6, 566-567 (2010).
13. Driggers, E.M. et al. Nat. Rev. Drug Discov. 7, 608-624 (2008).
14. Bonetta, L. Nature 468, 851-854 (2010).
15. Venkatesan, K. et al. Nat. Methods 6, 83-90 (2009).
16. Stumpf, M.P. et al. Proc. Natl. Acad. Sci. USA 105, 6959-6964 (2008).
17. Metz, J.T. & Hajduk, P.J. Curr. Opin. Chem. Biol. 14, 498-504 (2010).
18. Nisius, B. & Bajorath, J. Exp. Opin. Drug Discovery 6, 1-7 (2010).
19. Kromdijk, W. et al. Expert Opin. Pharmacother. 11, 1215-1223 (2010).
20. Drenth, J.P.H. & Waxman, S.G. J. Clin. Invest. 117, 3603-3609 (2007).
21. Cockburn, I. & Henderson, R. NBER Working Paper 6018 (National Bureau of Economic Research, Cambridge, Massachusetts, USA, 1997).
22. Frye, S.V. Nat. Chem. Biol. 6, 159-161 (2010).
23. Heal, W.P., Dang, T.H.T. & Tate, E.W. Chem. Soc. Rev. 40, 246-257 (2011).
24. Bunnage, M.E. (ed.) New Frontiers in Chemical Biology: Enabling Drug Discovery (Royal Society of Chemistry Drug Discovery Series, 2011).
25. Schmid, E.F. & Smith, D.A. Drug Discov. Today 12, 998-1006 (2007).
26. Bartfai, T. & Lees, G.V. Drug Discovery: From Bedside to Wall Street (Elsevier Academic Press, 2006).